BRIEF-US FDA says approved changes to Byetta label to include info on reports of altered kidney function - News

Runway Angels
The superbowl of fashion shows, models walk down the runway at the 2009 Victoria's Secret Fashion Show.
The Richest Members of the US Congress
Recently, the Center for Responsive Politics found that there are 237 millionaires in the US Congress.
10 Tips to Get Out of Debt
Renowned financial author Gail Vaz-Oxlade takes a tough-love approach to helping couples in a financial crisis to face reality.

FEATURED QUIZZES

How Much Do You Know About Green?
Green has become part of our everyday lives. Green is everywhere-- energy, clothing, food, housing, transportation. It's a big business and a global business.
The Billionaire BFF's
Philanthropists. Bridge partners. Hockey players. Which responses are based on facts from Buffett's and Gates' real lives?
The Many Myths of Coca-Cola
Can you tell which statements are true, and which ones are just rumors?

SPECIAL REPORTS

Winterizing Your Portfolio
If 2009 was the winter of our discontent, will 2010 be a winter wonderland for investors? A lot depends on the recovery—or lack thereof.
Investor's Guide to Real Estate
Some even say the long-awaited recovery is here. Regardless, buyers and sellers alike can profit from our guide.
Alternative Investing
Stocks and bonds? Sure. But it's a big world out there for investors.

CNBC ON DIGG

BRIEF-US FDA says approved changes to Byetta label to include info on reports of altered kidney function

By: AFX | 02 Nov 2009 | 02:51 PM ET

Text Size

Nov 2 (Reuters) - US FDA: * US FDA says approved changes to byetta label to include information on reports of altered kidney function, including acute renal failure * US FDA says received reports on 78 cases of altered kidney function in patients using lilly/amylin diabetes drug byetta from April 2005-October 2008 * US FDA says reported cases of altered renal function represent small percentage of total number of patients who have used the drug (New York Equities Desk; tel: +1 646 223 6000) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved.

The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.

Tools: